美国国家卫生研究院英国工作组关于COVID-19疫情期间及之后远程试验交付的报告
美国国家卫生研究院(NIHR)成立远程试验交付工作组,评估试验交付路径的五个关键领域,对研究人员及患者和照护者开展独立调查,构建了包含网站和最佳实践示例库的工具包,并提出远程试验交付的五项关键原则。
要点
- 患者和照护者调查收到47份回复,其中患者34人、照护者13人。
- 专业调查收集了来自英格兰各地的115个远程试验交付实践示例。
- 工作组提出远程试验交付五项关键原则:国家研究标准、包容性、有效性、成本效益和新方法评估。
核心结论
- COVID-19疫情催化下向远程试验交付的快速转变可能导致临床试验交付的持续变化。
- NIHR远程试验交付工作组提供工具包,推荐远程试验交付的五项关键原则并提供促成因素示例。
研究设计与样本
- NIHR远程试验交付工作组评估试验交付路径的五个关键领域:参与者因素、招募、干预交付、结局测量和质量保证。
- 独立调查分发给研究人员以及患者和照护者,以确定远程试验交付中的益处、挑战、陷阱、促成因素和良好实践示例。
- 构建了支持研究人员、资助者和治理结构迈向远程试验交付的工具包,包括一个网站和一个最佳实践示例与问题库。
- 患者和照护者调查收到47份回复,其中34人为患者、13人为照护者。
- 专业调查收集了来自英格兰各地的115个远程试验交付实践示例。
主要发现
- 患者和照护者调查回复者共47人,其中患者34人、照护者13人。
- 专业调查收集了来自英格兰各地的115个远程试验交付实践示例。
- 关键潜在益处包括更广泛覆盖和包容性、标准化和集中化能力以及提高效率和患者/照护者便利性。
- 挑战包括可能排除缺乏连接或数字技能的参与者、缺乏数字技能劳动力和适当基础设施以及验证要求。
- 提出了远程试验交付的五项关键原则:国家研究标准、包容性、有效性、成本效益和新方法评估。
关键数值与推荐
- 远程试验交付的五项关键原则:国家研究标准、包容性、有效性、成本效益和新方法评估。
- 患者和照护者调查回复者共47人,其中患者34人、照护者13人。
- 专业调查收集了来自英格兰各地的115个远程试验交付实践示例。
临床怎么用
- NIHR远程试验交付工作组提供工具包,推荐远程试验交付的五项关键原则并提供促成因素示例。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prior to the COVID-19 pandemic, the majority of clinical trial activity took place face to face within clinical or research units. The COVID-19 pandemic resulted in a significant shift towards trial delivery without in-person face-to-face contact or "Remote Trial Delivery". The National Institute of Health Research (NIHR) assembled a Remote Trial Delivery Working Group to consider challenges and enablers to this major change in clinical trial delivery and to provide a toolkit for researchers to support the transition to remote delivery. METHODS: The NIHR Remote Trial Delivery Working Group evaluated five key domains of the trial delivery pathway: participant factors, recruitment, intervention delivery, outcome measurement and quality assurance. Independent surveys were disseminated to research professionals, and patients and carers, to ascertain benefits, challenges, pitfalls, enablers and examples of good practice in Remote Trial Delivery. A toolkit was constructed to support researchers, funders and governance structures in moving towards Remote Trial Delivery. The toolkit comprises a website encompassing the key principles of Remote Trial Delivery, and a repository of best practice examples and questions to guide research teams. RESULTS: The patient and carer survey received 47 respondents, 34 of whom were patients and 13 of whom were carers. The professional survey had 115 examples of remote trial delivery practice entered from across England. Key potential benefits included broader reach and inclusivity, the ability for standardisation and centralisation, and increased efficiency and patient/carer convenience. Challenges included the potential exclusion of participants lacking connectivity or digital skills, the lack of digitally skilled workforce and appropriate infrastructure, and validation requirements. Five key principles of Remote Trial Delivery were proposed: national research standards, inclusivity, validity, cost-effectiveness and evaluation of new methodologies. CONCLUSIONS: The rapid changes towards Remote Trial Delivery catalysed by the COVID-19 pandemic could lead to sustained change in clinical trial delivery. The NIHR Remote Trial Delivery Working Group provide a toolkit for researchers recommending five key principles of Remote Trial Delivery and providing examples of enablers.
引用
- Masoli JAH, Down K, Nestor G, et al. A report from the NIHR UK working group on remote trial delivery for the COVID-19 pandemic and beyond. Trials. 2021. PMID: 34895305. doi:10.1186/s13063-021-05880-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。